基于“脾–卫–痹”模型探讨肠道菌群在类风湿性关节炎中的作用及中医药干预策略
The “Spleen-Wei-Bi” Axis: Exploring the Role of Gut Microbiome in Rheumatoid Arthritis and TCM Intervention Strategies
摘要: 类风湿性关节炎(Rheumatoid Arthritis, RA)是一种以滑膜炎症和渐进性关节损伤为特征的慢性自身免疫性疾病,其发生发展已被证实与肠道微生态失衡密切相关。文章基于中医学“脾为之卫”理论,构建“脾–卫–痹”动态失衡模型,该模型将RA病理演变划分为三个递进阶段:“脾虚失卫–邪乘虚入–痰瘀互结”。脾虚可致肠道菌群紊乱、肠屏障受损,是疾病发生的始动环节;卫气失固致使外邪乘隙侵入,激活免疫炎症级联反应,成为病情进展枢纽;痰瘀互结终致关节结构破坏、骨组织侵蚀,形成最终病理结局。研究通过临床研究、动物实验、网状Meta分析及孟德尔随机化研究从多维度为该理论模型提供了翔实证据,并以“脾–卫–痹”模型为指导,系统整合RA发病机制与中医药干预策略,为临床诊疗提供整体性思路。
Abstract: Rheumatoid arthritis (RA) is a chronic autoimmune disease driven by synovial inflammation and progressive joint damage, a process increasingly linked to gut microbiota dysbiosis. Drawing on the traditional Chinese medicine (TCM) principle that “the spleen governs defensive Qi (Wei-Qi)”, this article proposes a dynamic “Spleen-Wei-Bi” imbalance model. This model conceptualizes the pathological evolution of RA (Bi syndrome) through three sequential stages: “spleen deficiency with compromised defense, pathogen invasion due to vulnerability, intermingled phlegm and blood stasis”. Spleen deficiency, characterized by gut microbiota dysbiosis and impaired intestinal barrier function, serving as the initiating factor; failure of defensive Qi (Wei-Qi), which permits pathogen invasion and triggers a maladaptive immune-inflammatory cascade, representing the critical juncture in disease progression; intermingled phlegm and blood stasis, culminating in irreversible joint structural damage and bone erosion as the final pathological outcome. We substantiate this conceptual framework by integrating multi-dimensional evidence from clinical studies, animal experiments, network meta-analyses, and Mendelian randomization studies. By framing RA pathogenesis within the “Spleen-Wei-Bi” model, this review systematically aligns disease mechanisms with TCM intervention strategies, offering a holistic perspective for clinical management and future research.
文章引用:朱泽华, 高永翔. 基于“脾–卫–痹”模型探讨肠道菌群在类风湿性关节炎中的作用及中医药干预策略[J]. 中医学, 2026, 15(4): 13-19. https://doi.org/10.12677/tcm.2026.154175

参考文献

[1] Zaiss, M.M., Wu, H.J.J., Mauro, D., Schett, G. and Ciccia, F. (2021) The Gut-Joint Axis in Rheumatoid Arthritis. Nature Reviews Rheumatology, 17, 224-237. [Google Scholar] [CrossRef] [PubMed]
[2] Zhang, X., Zhang, D., Jia, H., Feng, Q., Wang, D., Liang, D., et al. (2015) The Oral and Gut Microbiomes Are Perturbed in Rheumatoid Arthritis and Partly Normalized after Treatment. Nature Medicine, 21, 895-905. [Google Scholar] [CrossRef] [PubMed]
[3] Brandtzaeg, P. (1997) Review Article: Homing of Mucosal Immune Cells—A Possible Connection between Intestinal and Articular Inflammation. Alimentary Pharmacology & Therapeutics, 11, 24-39. [Google Scholar] [CrossRef] [PubMed]
[4] 曲道炜, 于静. 仲景从脾论治痹证思考[J]. 辽宁中医药大学学报, 2023, 25(5): 141-144.
[5] 朱子衡, 黄传兵, 李明, 等. 从“脾为之卫”理论探讨痹证辨治体系构建及临床应用[J]. 时珍国医国药, 2026, 37(3): 519-523.
[6] 付皖兰, 曹云祥, 束龙武, 等. 基于新安固本培元理论探讨痹证从脾肾论治特色[J]. 中医药临床杂志, 2024, 36(6): 1024-1028.
[7] 李佩珊, 王树东. 基于“脾为之卫”理论辨治痹证[J]. 江苏中医药, 2022, 54(12): 38-40.
[8] 吴功义, 张胜友. 张胜友教授基于脾肾功能治疗痹证经验[J]. 光明中医, 2024, 39(18): 3665-3668.
[9] 彭记棚, 袁雪梅, 罗丰, 等. 基于2bRAD-M和LC-MS/MS探讨季节对类风湿性关节炎肠道菌群和代谢物的影响[J]. 海南医科大学学报, 2025, 31(6): 1-11.
[10] 叶露露, 庞宇舟, 唐秋媛, 等. 基于“毒虚致病”探讨类风湿性关节炎与肠道菌群的关系[J]. 中国中医基础医学杂志, 2025, 31(10): 1725-1729.
[11] Scher, J.U., Sczesnak, A., Longman, R.S., Segata, N., Ubeda, C., Bielski, C., et al. (2013) Expansion of Intestinal Prevotella copri Correlates with Enhanced Susceptibility to Arthritis. eLife, 2, e01202. [Google Scholar] [CrossRef] [PubMed]
[12] 易寒知, 王敏慧, 李湖帆, 等. 基于“肠-关节轴”探讨中医药治疗类风湿性关节炎的研究进展[J]. 云南中医中药杂志, 2024, 45(8): 87-91.
[13] 蒋妍, 张瑾, 王媛媛. 黄芪桂枝五物汤加减联合托法替布片对类风湿性关节炎患者肠道菌群和血清M1、M2型炎症因子的影响[J]. 中医药导报, 2025, 31(7): 1105-1110.
[14] 汪晓萍, 刘飞, 方兴刚. 清热活血方对类风湿性关节炎大鼠外周血T淋巴细胞及RAF-MEK1/MEK2信号的影响[J]. 中国中医基础医学杂志, 2025, 31(4): 567-573.
[15] 王鹏, 冯江, 刘雷, 等. 肠道菌群失调影响骨关节炎的机制及中药治疗机制的研究进展[J]. 现代中西医结合杂志, 2025, 34(12): 1789-1794.
[16] 王怡文, 王思维, 卫博文, 等. 基于“肠-关节”轴探究肠道菌群与类风湿性关节炎的因果关系及潜在干预中药预测[J]. 中草药, 2025, 56(2): 585-597.
[17] 张雨蒙, 靳海珠, 刘杨, 等. 基于肠道菌群探讨中医药防治类风湿性关节炎的作用[J]. 中药材, 2024, 47(10): 2657-2663.
[18] 周燕, 万秀才, 袁锐, 等. 耐受性树突状细胞对胶原诱导性关节炎大鼠肠道菌群结构的影响[J]. 中国免疫学杂志, 2026, 42(1): 20-27.
[19] 张红林, 蒋海旭, 韦秋竹, 等. 基于肠-关节轴探讨中药治疗类风湿性关节炎的研究进展[J]. 中国实验方剂学杂志, 2024, 30(6): 262-268.
[20] 刘源, 姜萍. 基于“体脏合痹”理论探讨中医药调节肺肠轴防治类风湿性关节炎合并肺间质病变的机制[J]. 中国中医基础医学杂志, 2025, 31(2): 123-128.
[21] 李辉, 谢金洙, 樊若溪, 等. 四君子汤对2型糖尿病小鼠肠屏障的影响[J]. 中国中药杂志, 2024, 49(16): 4389-4396.
[22] 陈虹伊, 许超. 祛风除湿法中药复方治疗类风湿性关节炎的Meta分析与代表方——防己黄芪汤的网络药理学研究[D]: [硕士学位论文]. 南京: 南京中医药大学, 2025.
[23] 沈子扬, 刘树民, 于栋华. 5种中药汤剂治疗类风湿性关节炎有效性和安全性的网状Meta分析[J]. 中国循证医学杂志, 2025, 25(3): 267-276.
[24] 王敏慧, 易寒知, 朱丹, 等. 基于肠道菌群探讨中药干预类风湿性关节炎的研究进展[J]. 风湿病与关节炎, 2024, 13(8): 67-71.
[25] 张洪瑞, 武瑞骐, 王文驰, 等. 雷公藤活性成分防治类风湿性关节炎的分子机制[J]. 中国组织工程研究, 2026, 30(28): 7332-7339.
[26] Jubair, W.K., Hendrickson, J.D., Severs, E.L., Schulz, H.M., Adhikari, S., et al. (2018) Modulation of Inflammatory Arthritis in Mice by Gut Microbiota through Mucosal Inflammation and Autoantibody Generation. Arthritis & Rheumatology, 70, 1220-1233. [Google Scholar] [CrossRef] [PubMed]
[27] 陈杰, 崔景波, 吕昌龙, 等. 基于“肠-关节轴”探讨中药-肠道菌群互作治疗自身免疫性关节炎研究新进展[J]. 中国免疫学杂志, 2024, 40(11): 2434-2439.